Risk Factors Related to COVID-19 Reinfection and Fatality During the Omicron (BA.1/BA. 2) Period in Korea

被引:5
作者
Lee, Ju Hee [1 ]
Hwang, Ji Hae [1 ]
Jang, Eun Jung [1 ]
Kim, Ryu Kyung [1 ]
Lee, Kil Hun [1 ]
Park, Seon Kyeong [1 ]
Gwack, Jin [2 ]
Park, Young Joon [1 ]
机构
[1] Korea Dis Control & Prevent Agcy, Div Epidemiol Invest Anal, 187 Osongsaengmyeong 2 Ro, Cheongju 28159, South Korea
[2] Korea Dis Control & Prevent Agcy, Div Infect Dis Control, Cheongju, South Korea
关键词
COVID-19; Reinfection; SARS-CoV-2; SARS-CoV-2 Omicron Variant; Death;
D O I
10.3346/jkms.2023.38.e269
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: This study aimed to investigate the deaths due to coronavirus disease 2019 (COVID-19) reinfection and related risk factors. Methods: National cohort data were collected for a six-month period when omicron BA.1/ BA.2 variant was dominant in South Korea. Results: The long-term care facility residents (adjusted odds ratio, 3.11; 95% confidence interval [CI], 2.98-3.25) had significantly higher risk of reinfection than the general population. The risk of reinfection was significantly lower for persons with 2 or more vaccine doses compared to the unvaccinated. The risk of death was significantly higher in the reinfection group than in the primary infection group for persons in the 60-74 years age group (adjusted relative risk [aRR], 1.62; 95% CI, 1.19-2.20), and immunocompromised group (aRR, 4.56; 95% CI, 2.34-8.90). Conclusion: In these data, vaccination history was significantly related to reduced COVID-19 reinfection and severe progression, and scheduled vaccinations were important even with a history of infection.
引用
收藏
页数:9
相关论文
共 18 条
[1]   Impact of the Omicron variant on SARS-CoV-2 reinfections in France, March 2021 to February 2022 [J].
Bastard, Jonathan ;
Taisne, Benjamin ;
Figoni, Julie ;
Mailles, Alexandra ;
Durand, Julien ;
Fayad, Myriam ;
Josset, Laurence ;
Maisa, Anna ;
van der Werf, Sylvie ;
du Chatelet, Isabelle Parent ;
Bernard-Stoecklin, Sibylle .
EUROSURVEILLANCE, 2022, 27 (13)
[2]  
Boyeong Ryu ES, 2022, Public Health Wkly Rep, V15, P2873
[3]  
Cavanaugh AM, 2021, MMWR-MORBID MORTAL W, V70, P1081, DOI [10.15585/mmwr.mm7032e1externalicon, 10.15585/mmwr.mm7032e1]
[4]  
Deng Jie, 2023, Int J Environ Res Public Health, V20, DOI 10.3390/ijerph20043335
[5]   A simple method for estimating relative risk using logistic regression [J].
Diaz-Quijano, Fredi A. .
BMC MEDICAL RESEARCH METHODOLOGY, 2012, 12
[6]   Reinfection with SARS-CoV-2 in general population, South Korea; nationwide retrospective cohort study [J].
Jang, Eun Jung ;
Choe, Young June ;
Yun, Go-Woon ;
Wang, Seongjin ;
Cho, U. Jin ;
Yi, Seonju ;
Lee, Sangwon ;
Park, Young-Joon .
JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (11) :5589-5592
[7]   Effectiveness of Second mRNA COVID-19 Booster Vaccine in Immunocompromised Persons and Long-Term Care Facility Residents [J].
Kim, Yoo-Yeon ;
Choe, Young June ;
Kim, Jia ;
Kim, Ryu Kyung ;
Jang, Eun Jung ;
Park, Seon Kyeong ;
Lim, Do-Sang ;
Yi, Seonju ;
Lee, Sangwon ;
Kwon, Geun-Yong ;
Shin, Jee Yeon ;
Choi, Sang-Yoon ;
Jeong, Mi Jin ;
Park, Young-Joon .
EMERGING INFECTIOUS DISEASES, 2022, 28 (11) :2165-2170
[8]   Effectiveness Associated With Vaccination After COVID-19 Recovery in Preventing Reinfection [J].
Lewis, Nickolas ;
Chambers, Laura C. ;
Chu, Huong T. ;
Fortnam, Taylor ;
De Vito, Roberta ;
Gargano, Lisa M. ;
Chan, Philip A. ;
McDonald, James ;
Hogan, Joseph W. .
JAMA NETWORK OPEN, 2022, 5 (07) :E2223917
[9]   Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting [J].
Magen, Ori ;
Waxman, Jacob G. ;
Makov-Assif, Maya ;
Vered, Roni ;
Dicker, Dror ;
Hernan, Miguel A. ;
Lipsitch, Marc ;
Reis, Ben Y. ;
Balicer, Ran D. ;
Dagan, Noa .
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (17) :1603-1614
[10]   SARS-CoV-2 reinfections during the first three major COVID-19 waves in Bulgaria [J].
Marinov, Georgi K. ;
Mladenov, Mladen ;
Rangachev, Antoni ;
Alexiev, Ivailo .
PLOS ONE, 2022, 17 (09)